New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo

Nenhuma Miniatura disponível

Data

2015-06-01

Autores

Soares, Roberta Reis
Silva, José Marcio Fernandes da
Carlos, Bianca Cechetto [UNESP]
Fonseca, Camila Campos da
Souza, Laila Salomé Araújo de
Lopes, Fernanda Valério
Dias, Rafael Mafra de Paula
Moreira, Paulo Otávio Lourenço
Abramo, Clarice
Viana, Gustavo Henrique Ribeiro

Título da Revista

ISSN da Revista

Título de Volume

Editor

Elsevier B.V.

Resumo

Malaria continues to be an important public health problem in the world. Nowadays, the widespread parasite resistance to many drugs used in antimalarial therapy has made the effective treatment of cases and control of the disease a constant challenge. Therefore, the discovery of new molecules with good antimalarial activity and tolerance to human use can be really important in the further treatment of the disease. In this study we have investigated the antiplasmodial activity of 10 synthetic compounds derived from quinoline, five of them combined to sulfonamide and five to the hydrazine or hydrazide group. The compounds were evaluated according to their cytotoxicity against HepG2 and HeLa cell lines, their antimalarial activity against CQ-sensitive and CQ-resistant Plasmodium falciparum strains and, finally, their schizonticide blood action in mice infected with Plasmodium berghei NK65. The compounds exhibited no cytotoxic action in HepG2 and HeLa cell lines when tested up to a concentration of 100 mu g/mL. In addition, the hydrazine or hydrazide derivative compounds were less cytotoxic against cell lines and more active against CQ-sensitive and CQ-resistant P. falciparum strains, showing high SI (> 1000 when SI was calculated using the CC50 from the 3D7 strain as reference). When tested in vivo, the hydrazine derivative 1f compound showed activity against the development of blood parasites similar to that observed with CQ, the reference drug. Interestingly, the 1f compound demonstrated the best LipE value (4.84) among all those tested in vivo. Considering the in vitro and in vivo activities of the compounds studied here and the LipE values, we believe the 1f compound to be the most promising molecule for further studies in antimalarial chemotherapy.

Descrição

Palavras-chave

Plasmodium falciparum, Malaria, Antimalarial chemotherapy, Cytotoxicity, Quinoline derivatives

Como citar

Bioorganic & Medicinal Chemistry Letters. Oxford: Pergamon-elsevier Science Ltd, v. 25, n. 11, p. 2308-2313, 2015.

Coleções